Congress Subpoenas Medical Organizations

A US House of Representatives panel has requested information from several research bodies and abortion providers as part of a sweeping investigation of fetal tissue research.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, JOHANNES JANSSONA Congressional panel tasked with investigating the issue of fetal tissue research has issued a dozen subpoenas to researchers, medical organizations, and abortion providers. The House Select Investigative Panel on Infant Lives was launched in the wake of the now-infamous undercover videos that purported to show Planned Parenthood officials trying to illegally profit from the sale of fetal tissues destined for research. The videographers of that footage were recently indicted in Texas, but the House of Representatives investigation is ramping up—with legislators on the panel compiling lists of researchers in the fetal tissue research field—much to the dismay of research advocates and abortion rights groups.

The American Congress of Obstetricians and Gynecologists was one of the loudest voices descrying the investigation. “Unfortunately, some state and federal politicians are working hard to obstruct—or even criminalize—fetal tissue research, limiting the ability of scientists and researchers to develop new vaccines and medicines to prevent and treat disease,” the group said in a statement posted last week (March 30).

The panel’s subpoenas even included individual faculty members at the University of New Mexico (UNM) in Albuquerque, according to Science. UNM told Science that it has provided the panel with roughly 3,000 pages of documents, but refused to reveal the identities of faculty and students involved in the research. And STAT News reported last week (March 31) that one of the subpoenaed institutions, Ganogen, was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies